Biotech · Private company · Boca Raton, FL, US

Aventusoft, LLC.

Track this companyFree. Adds Aventusoft, LLC. to your Dealase workspace and tells you when its record changes.

Clinical trials21 recruiting or active

Pipeline programs1From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline1

PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAGRECRUITING · started Mar 14, 2024ClinicalTrials.gov NCT06567795 · fetched Nov 12, 2026
HEMOTAG® Assessment for Short-term Outcomes of Heart FailureNA · UNKNOWN · started Jan 31, 2022ClinicalTrials.gov NCT04149743 · fetched Nov 12, 2026

A Smart Remote Monitoring System for Cardiometabolic Management in Patients with Alzheimer's and Related DementiaFiscal year 2026 · $500KNIH RePORTER 1R43AG099700-01 · fetched Nov 12, 2026
Commercialization Readiness Pilot Program support for: HEMOLINKFiscal year 2026 · $500KNIH RePORTER 1SB1HL184385-01 · fetched Nov 12, 2026
Non-invasive cloud connected device for hemodynamic-guided therapy to improve outcomes for heart failure patientsFiscal year 2026 · $1.2MNIH RePORTER 2R44HL145941-04 · fetched Nov 12, 2026
An Innovative AI-Powered Wearable Physiological Sensor System for Real-Time Pain Monitoring and Management (PainVitals)Fiscal year 2025 · $349.9KNIH RePORTER 1R41GM162038-01 · fetched Nov 12, 2026
Commercialization Readiness Pilot Program support for: HATS-OFFFiscal year 2025 · $500KNIH RePORTER 1SB1HL180153-01 · fetched Nov 12, 2026
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.Fiscal year 2025 · $860.4KNIH RePORTER 5R44HL167296-03 · fetched Nov 12, 2026
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.Fiscal year 2024 · $864.8KNIH RePORTER 4R44HL167296-02 · fetched Nov 12, 2026